In 2021, the FDA was on the fence about whether to approve a new treatment for a rare form of vasculitis. After an advisory committee narrowly recommended approval, the agency greenlit the drug, Tavneos, and it started making its way into clinics. After uncovering evidence of what it says is data manipulation in the original trial, the agency wants to rescind the approval. But it’s not so easy.
Sprouts Farmers Market Inc. shares tumbled after cutting its outlook, as the grocer’s sales suffered from the cyclospora lettuce outbreak and a gloomy consumer.
Beauty has long been described as something that makes us pause and look. Neuroscientists in Italy tested that idea by recording brain activity while people viewed nature photos, and found signs that…
The pharmaceutical giant reported beat third-quarter sales and profit expectations, driven by a 15% rise in demand for its specialty HIV and respiratory medicines.
Presented by Alliance for Aging Research {beacon} Health Care Health Care The Big Story HHS gives compounding pharmacies free rein to make certain peptides Without finalizing any new approvals or…
